Axa’s Fabrinet FN Stock Holding History

Axa’s Portfolio FN Stock Details FN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-60,000	Closed	-$2.22M	–	1362
2017 Q3	$2.22M	Buy	60,000 +8,000	+15%	+$327K	0.01%	793
2017 Q2	$2.22M	Hold	52,000	–	–	0.01%	764
2017 Q1	$2.19M	Buy	52,000 +10,000	+24%	+$415K	0.01%	764
2016 Q4	$1.69M	Buy	+42,000	New	+$1.75M	0.01%	794

Other funds holding FN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

Axa's FN Position: Q4 2017 in Review

Axa sold out of Fabrinet (FN) in Q4 2017, closing a stake of 60,000 shares — an estimated $2.22M sold.

Axa first reported a position in FN in Q4 2016 and held it in 4 quarters. The position peaked at $2.22M in Q3 2017. 201 funds tracked by Wall St. Rank hold FN as of Q4 2017.

Axa reported no remaining Fabrinet position as of Q4 2017 after selling out during the quarter.
Axa sold 60,000 Fabrinet shares in Q4 2017, an estimated $2.22M.
Axa first reported a position in Fabrinet in Q4 2016 and held it in 4 quarters.
Axa's Fabrinet position peaked at $2.22M in Q3 2017.
201 funds tracked by Wall St. Rank held Fabrinet as of Q4 2017.

Based on Axa's 13F filing for Q4 2017, filed 13 Feb 2018.